Delivery Order SPE2DB24D1205-SPE2DB24FCQYQ
Award Date
5/2/24
Potential Completion Date
5/23/24
Potential Value
$4.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a ceiling value of $13,862.79 and a performance period through May 28, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 fixed-price delivery order is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication, with a completion date of November 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a $4,620.93 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract has a firm-fixed price pricing type and a completion date of December 16, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $13,399.71 to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor and for-profit organization. The contract is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product, with a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,399.71 firm-fixed-price delivery order is for the supply of the medication ZEPOSIA 0.92 MG CAPSULE 30S. The contract has an ultimate completion date of December 3, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corporation for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a ceiling value of $13,399.71 and an ultimate completion date of September 25, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this contract as part of its ongoing efforts to provide...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of ZEPOSIA 0.92 MG CAPSULE 30S. The contract has a firm fixed price of $4,466.57 and a completion date of October 15, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
The Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $8,933.14 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation. The contract is for the supply of ZEPOSIA 0.92 MG CAPSULE 30S, a pharmaceutical product, with a period of performance through August 2, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,862.79, covers the procurement of ZEPOSIA 0.92 MG CAPSULE 30S, a medication, for the agency. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,466.57, is for the delivery of ZEPOSIA 0.92 MG CAPSULE 30S, a prescription medication. The contract is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...